Efg Asset Management (North America) Corp. Xencor Inc Transaction History

Efg Asset Management (North America) Corp.

$705 Million
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$24.77 - $29.9 $4.08 Million - $4.93 Million	-164,735 Reduced 79.09%	43,555 $1.09 Million
Q1 2023 Apr 27, 2023	SELL	$25.95 - $36.95 $913,336 - $1.3 Million	-35,196 Reduced 14.46%	208,290 $5.81 Million
Q4 2022 Feb 03, 2023	SELL	$24.79 - $30.86 $225,365 - $280,548	-9,091 Reduced 3.6%	243,486 $6.34 Million
Q3 2022 Oct 28, 2022	SELL	$24.62 - $32.44 $724,862 - $955,098	-29,442 Reduced 10.44%	252,577 $6.57 Million
Q2 2022 Aug 04, 2022	SELL	$19.74 - $29.01 $563,517 - $828,148	-28,547 Reduced 9.19%	282,019 $7.73 Million
Q1 2022 Apr 26, 2022	SELL	$26.68 - $41.63 $13,233 - $20,648	-496 Reduced 0.16%	310,566 $8.28 Million
Q4 2021 Feb 18, 2022	BUY	$33.67 - $43.44 $10.5 Million - $13.5 Million	311,062 New	311,062 $12.5 Million

Others Institutions Holding XNCR

# of Institutions

199

Shares Held

73.7M

Call Options Held

1.7K

Put Options Held

4.2K

Black Rock Inc. New York, NY

11.1M
Shares

$149 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

8.98M
Shares

$121 Million
0.16% of portfolio
Vanguard Group Inc Valley Forge, PA

8.02M
Shares

$108 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.14M
Shares

$82.6 Million
6.6% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.04M
Shares

$54.3 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $803M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account